Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Tables)

v3.22.2
Restatement of Previously Issued Financial Statements (Tables)
3 Months Ended
Mar. 31, 2022
Condensed Financial Information Disclosure [Abstract]  
Schedule of adjustments on the restated financial statements consolidated balance sheet
Consolidated Balance Sheet as of March 31, 2022   As
Previously Reported
    Adjustment     As
Restated
 
Accounts payable and accrued liabilities   $ 43,933     $ 1,028     $ 44,961  
Other liabilities   $ 81,948     $ 9,933     $ 91,881  
Total liabilities   $ 371,146     $ 10,961     $ 382,107  
Redeemable convertible preferred stock (Series A)   $ 194,675     $ (1,028 )   $ 193,647  
Additional paid-in capital   $ 723,394     $ (1,346 )   $ 722,048  
Accumulated deficit   $ (470,304 )   $ (8,587 )   $ (478,891 )
Total stockholders’ equity   $ 243,414     $ (9,933 )   $ 233,481  

 

Consolidated Balance Sheet as of December 31, 2021   As
Previously Reported
    Adjustment     As
Restated
 
Other liabilities   $ 26,585     $ 11,550     $ 38,135  
Total liabilities   $ 258,304     $ 11,550     $ 269,854  
Additional paid-in capital   $ 708,175     $ (6,941 )   $ 701,234  
Accumulated deficit   $ (465,264 )   $ (4,609 )   $ (469,873 )
Total stockholders’ equity   $ 233,234     $ (11,550 )   $ 221,684  

 

Schedule of adjustments on the restated financial statements consolidated statement of operations
Consolidated Statement of Operations for the Three Months Ended March 31, 2022   As
Previously
Reported
    Adjustment     As
Restated
 
    (amounts in thousands except share
and per share amounts)
 
Change in fair value of contingent consideration from mergers and acquisitions   $ (682 )   $ (3,978 )   $ (4,660 )
Net loss before income taxes   $ (34,417 )   $ (3,978 )   $ (38,395 )
Net loss   $ (6,000 )   $ (3,978 )   $ (9,978 )
Net loss attributable to common shareholders   $ (7,028 )   $ (3,978 )   $ (11,006 )
Net loss per share, basic and diluted   $ (0.03 )   $ (0.02 )   $ (0.05 )

 

Schedule of adjustments on the restated financial statements consolidated statement of cash flows
Consolidated Statement of Cash Flows for the Three Months Ended March 31, 2022   As
Previously
Reported
    Adjustment     As
Restated
 
Net loss   $ (6,000 )   $ (3,978 )   $ (9,978 )
Change in fair value of contingent consideration from mergers and acquisitions   $ 682     $ 3,978     $ 4,660